You just read:

FDA Approves XARELTO® (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery

News provided by

Janssen Pharmaceuticals, Inc.

Jul 01, 2011, 03:00 ET